Literature DB >> 11160211

Signal via lymphotoxin-beta R on bone marrow stromal cells is required for an early checkpoint of NK cell development.

Q Wu1, Y Sun, J Wang, X Lin, Y Wang, L E Pegg, A Fütterer, K Pfeffer, Y X Fu.   

Abstract

NK cells play an important role in the immune system but the cellular and molecular requirements for their early development are poorly understood. Lymphotoxin-alpha (LTalpha)(-/-) and LTbetaR(-/-) mice show a severe systemic reduction of NK cells, which provides an excellent model to study NK cell development. In this study, we show that the bone marrow (BM) or fetal liver cells from LTalpha(-/-) or LTbetaR(-/-) mice efficiently develop into mature NK cells in the presence of stromal cells from wild-type mice but not from LTalpha(-/-) or LTbetaR(-/-) mice. Direct activation of LTbetaR-expressing BM stromal cells is shown to promote to early NK cell development in vitro. Furthermore, the blockade of the interaction between LT and LTbetaR in adult wild-type mice by administration of LTbetaR-Ig impairs the development of NK cells in vivo. Together, these results indicate that the signal via LTbetaR on BM stromal cells by membrane LT is an important pathway for early NK cell development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160211     DOI: 10.4049/jimmunol.166.3.1684

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Stromal-cell regulation of natural killer cell differentiation.

Authors:  Claude Roth; Carla Rothlin; Sylvain Riou; David H Raulet; Greg Lemke
Journal:  J Mol Med (Berl)       Date:  2007-04-11       Impact factor: 4.599

Review 2.  LIGHT-related molecular network in the regulation of innate and adaptive immunity.

Authors:  Yanhui Xu; Koji Tamada; Lieping Chen
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 3.  Extrinsic and intrinsic regulation of early natural killer cell development.

Authors:  Markus D Boos; Kevin Ramirez; Barbara L Kee
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 4.  Immunoregulation by tumor necrosis factor superfamily member LIGHT.

Authors:  Yugang Wang; Mingzhao Zhu; Mendy Miller; Yang-Xin Fu
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 5.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

6.  Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease.

Authors:  Yanhui Xu; Andrew S Flies; Dallas B Flies; Gefeng Zhu; Sudarshan Anand; Sarah J Flies; Haiying Xu; Robert A Anders; Wayne W Hancock; Lieping Chen; Koji Tamada
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

Review 7.  Restoring immune defenses via lymphotoxin signaling: lessons from cytomegalovirus.

Authors:  Theresa A Banks; Sandra Rickert; Carl F Ware
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

8.  Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction.

Authors:  S Magez; B Stijlemans; G Caljon; H-P Eugster; P De Baetselier
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

9.  Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation.

Authors:  Eliseo F Castillo; Spencer W Stonier; Loredana Frasca; Kimberly S Schluns
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

10.  Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5.

Authors:  Ryan D Schulteis; Haiyan Chu; Xuezhi Dai; Yuhong Chen; Brandon Edwards; Dipica Haribhai; Calvin B Williams; Subramaniam Malarkannan; Martin J Hessner; Sanja Glisic-Milosavljevic; Srikanta Jana; Edward J Kerschen; Soumitra Ghosh; Demin Wang; Anne E Kwitek; Ake Lernmark; Jack Gorski; Hartmut Weiler
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.